Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

被引:400
作者
Bruce, Ian N. [1 ,2 ]
O'Keeffe, Aidan G.
Farewell, Vern [3 ]
Hanly, John G. [4 ,5 ,6 ]
Manzi, Susan [7 ]
Su, Li [3 ]
Gladman, Dafna D. [8 ,9 ]
Bae, Sang-Cheol [10 ]
Sanchez-Guerrero, Jorge [8 ,9 ]
Romero-Diaz, Juanita [11 ]
Gordon, Caroline [12 ]
Wallace, Daniel J. [13 ]
Clarke, Ann E. [14 ]
Bernatsky, Sasha [15 ,16 ]
Ginzler, Ellen M. [17 ]
Isenberg, David A. [18 ]
Rahman, Anisur [18 ]
Merrill, Joan T. [19 ]
Alarcon, Graciela S. [20 ]
Fessler, Barri J. [20 ]
Fortin, Paul R. [21 ,22 ]
Petri, Michelle [23 ]
Steinsson, Kristjan [24 ]
Dooley, Mary Anne [25 ]
Khamashta, Munther A. [26 ]
Ramsey-Goldman, Rosalind [27 ,28 ]
Zoma, Asad A. [29 ]
Sturfelt, Gunnar K. [30 ]
Nived, Ola [30 ]
Aranow, Cynthia [31 ]
Mackay, Meggan [31 ]
Ramos-Casals, Manuel [32 ]
van Vollenhoven, Ronald F. [33 ]
Kalunian, Kenneth C. [34 ]
Ruiz-Irastorza, Guillermo [35 ]
Lim, Sam [36 ]
Kamen, Diane L. [37 ]
Peschken, Christine A. [38 ]
Inanc, Murat [39 ]
Urowitz, Murray B. [8 ,9 ]
机构
[1] Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Inflammat & Repair, Arthrit Res UK,Ctr Epidemiol,Ctr Musculoskeletal, Manchester M13 9PT, Lancs, England
[2] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, NIHR Manchester Musculoskeletal Biomed Res Unit, Kellgren Ctr Rheumatol, Manchester, Lancs, England
[3] MRC, Biostat Unit, Cambridge CB2 2BW, England
[4] Queen Elizabeth 2 Hlth Sci Ctr, Dept Med, Div Rheumatol, Halifax, NS, Canada
[5] Queen Elizabeth 2 Hlth Sci Ctr, Dept Pathol, Halifax, NS, Canada
[6] Dalhousie Univ, Halifax, NS, Canada
[7] West Penn Allegheny Hlth Syst, Dept Med, Pittsburgh, PA USA
[8] Toronto Western Hosp, Ctr Prognosis Studies Rheumat Dis, Toronto, ON M5T 2S8, Canada
[9] Univ Toronto, Toronto, ON, Canada
[10] Hanyang Univ, Hosp Rheumat Dis, Dept Rheumatol, Seoul 133791, South Korea
[11] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico
[12] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Rheumatol Res Grp, Birmingham, W Midlands, England
[13] Univ Calif Los Angeles, Cedars Sinai David Geffen Sch Med, Los Angeles, CA USA
[14] Univ Calgary, Div Rheumatol, Calgary, AB T2N 1N4, Canada
[15] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Div Clin Immunol Allergy, Montreal, PQ H3G 1A4, Canada
[16] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ H3G 1A4, Canada
[17] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA
[18] UCL, Ctr Rheumatol Res, London, England
[19] Oklahoma Med Res Fdn, Dept Clin Pharmacol, Oklahoma City, OK 73104 USA
[20] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA
[21] Ctr Hosp Univ Quebec, Div Rheumatol, Quebec City, PQ, Canada
[22] Univ Laval, Quebec City, PQ, Canada
[23] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD USA
[24] Landspitali Univ Hosp, Ctr Rheumatol Res, Reykjavik, Iceland
[25] Univ N Carolina, Dept Med, Div Rheumatol, Chapel Hill, NC USA
[26] Kings Coll London, Sch Med, St Thomas Hosp, Rayne Inst,Lupus Res Unit, London, England
[27] Northwestern Univ, Chicago, IL 60611 USA
[28] Feinberg Sch Med, Chicago, IL USA
[29] Hairmyres Hosp, Lanarkshire Ctr Rheumatol, E Kilbride, Lanark, Scotland
[30] Univ Lund Hosp, Dept Rheumatol, S-22185 Lund, Sweden
[31] Feinstein Inst Med Res, Manhasset, NY USA
[32] Hosp Clin Barcelona, Dept Autoimmune Dis, IDIBAPS, Josep Font Autoimmune Dis Lab, Barcelona, Spain
[33] Karolinska Inst, Unit Clin Therapy Res Inflammatory Dis ClinTRID, Stockholm, Sweden
[34] UCSD Sch Med, La Jolla, CA USA
[35] Univ Basque Country, Hosp Univ Cruces, BioCruces Hlth Res Inst, Dept Internal Med,Autoimmune Dis Res Unit, Baracaldo, Spain
[36] Emory Univ, Atlanta, GA 30322 USA
[37] Med Univ S Carolina, Div Rheumatol & Immunol, Charleston, SC 29425 USA
[38] Univ Manitoba, Winnipeg, MB, Canada
[39] Istanbul Univ, Istanbul Fac Med, Dept Internal Med, Div Rheumatol, Istanbul, Turkey
基金
英国惠康基金; 美国国家卫生研究院; 英国医学研究理事会;
关键词
3; ETHNIC-GROUPS; DISEASE-ACTIVITY; ORGAN DAMAGE; CLINICS/AMERICAN-COLLEGE; INDEX; MORTALITY; TIME; PREDICTORS; ANTIBODIES;
D O I
10.1136/annrheumdis-2013-205171
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims We studied damage accrual and factors determining development and progression of damage in an international cohort of systemic lupus erythematosus (SLE) patients. Methods The Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort recruited patients within 15 months of developing four or more 1997 American College of Rheumatology (ACR) criteria for SLE; the SLICC/ACR damage index (SDI) was measured annually. We assessed relative rates of transition using maximum likelihood estimation in a multistate model. The Kaplan-Meier method estimated the probabilities for time to first increase in SDI score and Cox regression analysis was used to assess mortality. Results We recruited 1722 patients; mean (SD) age 35.0 (13.4) years at cohort entry. Patients with damage at enrolment were more likely to have further worsening of SDI (SDI 0 vs >= 1; p< 0.001). Age, USA African race/ethnicity, SLEDAI-2K score, steroid use and hypertension were associated with transition from no damage to damage, and increase(s) in pre-existing damage. Male gender (relative transition rates (95% CI) 1.48 (1.06 to 2.08)) and USA Caucasian race/ethnicity (1.63 (1.08 to 2.47)) were associated with SDI 0 to >= 1 transitions; Asian race/ethnicity patients had lower rates of new damage (0.60 (0.39 to 0.93)). Antimalarial use was associated with lower rates of increases in pre-existing damage (0.63 (0.44 to 0.89)). Damage was associated with future mortality (HR (95% CI) 1.46 (1.18 to 1.81) per SDI point). Conclusions Damage in SLE predicts future damage accrual and mortality. We identified several potentially modifiable risk factors for damage accrual; an integrated strategy to address these may improve long-term outcomes.
引用
收藏
页码:1706 / 1713
页数:8
相关论文
共 27 条
  • [1] Systemic lupus erythematosus in three ethnic groups.: XX.: Damage as a predictor of further damage
    Alarcón, GS
    Roseman, JM
    McGwin, G
    Uribe, A
    Bastian, HM
    Fessler, BJ
    Baethge, BA
    Friedman, AW
    Reveille, JD
    [J]. RHEUMATOLOGY, 2004, 43 (02) : 202 - 205
  • [2] Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
    Appel, Gerald B.
    Contreras, Gabriel
    Dooley, Mary Anne
    Ginzler, Ellen M.
    Isenberg, David
    Jayne, David
    Li, Lei-Shi
    Mysler, Eduardo
    Sanchez-Guerrero, Jorge
    Solomons, Neil
    Wofsy, David
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (05): : 1103 - 1112
  • [3] Becker-Merok A, 2006, J RHEUMATOL, V33, P1570
  • [4] Initial and accrued damage as predictors of mortality in Brazilian patients with systemic lupus erythematosus: a cohort study
    Cardoso, C. R. L.
    Signorelli, F. V.
    Papi, J. A. S.
    Salles, G. F.
    [J]. LUPUS, 2008, 17 (11) : 1042 - 1048
  • [5] Accrual of organ damage over time in Argentine patients with systemic lupus erythematosus: a multi-centre study
    Cassano, Gustavo
    Roverano, Susana
    Paira, Sergio
    Bellomio, Veronica
    Lucero, Eleonora
    Berman, Alberto
    Spindler, Alberto
    Trobo, Rosana
    Somma, Luis Fernando
    Graf, Cesar
    Barrionuevo, Alejandra
    Papasidero, Silvia
    Rillo, Oscar
    [J]. CLINICAL RHEUMATOLOGY, 2007, 26 (12) : 2017 - 2022
  • [6] Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years
    Chambers, Sharon A.
    Allen, Elizabeth
    Rahman, Anisur
    Isenberg, David
    [J]. RHEUMATOLOGY, 2009, 48 (06) : 673 - 675
  • [7] Systemic lupus erythematosus in three ethnic groups -: XVI.: Association of hydroxychloroquine use with reduced risk of damage accrual
    Fessler, BJ
    Alarcón, GS
    McGwin, G
    Roseman, J
    Bastian, HM
    Friedman, AW
    Baethge, BA
    Vilá, L
    Reveille, JD
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (05): : 1473 - 1480
  • [8] The development and initial validation of the systemic lupus international collaborating clinics American College of Rheumatology Damage Index for Systemic Lupus Erythematosus
    Gladman, D
    Ginzler, E
    Goldsmith, C
    Fortin, P
    Liang, M
    Urowitz, M
    Bacon, P
    Bombardieri, S
    Hanly, J
    Hay, E
    Isenberg, D
    Jones, J
    Kalunian, K
    Maddison, P
    Nived, O
    Petri, M
    Richter, M
    SanchezGuerrero, J
    Snaith, M
    Sturfelt, G
    Symmons, D
    Zoma, A
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (03): : 363 - 369
  • [9] The reliability of the systemic Lupus International Collaborating Clinics American College of Rheumatology Damage Index in patients with Systemic Lupus Erythematosus
    Gladman, DD
    Urowitz, MB
    Goldsmith, CH
    Fortin, P
    Ginzler, E
    Gordon, C
    Hanly, JG
    Isenberg, DA
    Kalunian, K
    Nived, O
    Petri, M
    SanchezGuerrero, J
    Snaith, M
    Sturfelt, G
    [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (05): : 809 - 813
  • [10] Gladman DD, 2002, J RHEUMATOL, V29, P288